Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Other Assets (Bank)
$549.53 Mil (As of Jun. 2014)

Synageva BioPharma Corp's quarterly other assets (bank) increased from Dec. 2013 ($417.34 Mil) to Mar. 2014 ($586.37 Mil) but then declined from Mar. 2014 ($586.37 Mil) to Jun. 2014 ($549.53 Mil).

Synageva BioPharma Corp's annual other assets (bank) increased from Dec. 2011 ($62.50 Mil) to Dec. 2012 ($222.55 Mil) and increased from Dec. 2012 ($222.55 Mil) to Dec. 2013 ($417.34 Mil).


Banks frequently group a variety of accounts as “other assets” on their balance sheets. Banks must report several of these accounts, such as investment in unconsolidated subsidiaries, customer liability on outstanding acceptances, and intangible assets as separate line items on Call Reports.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

BS_other_assets_Bank 54.7144.5856.8277.5139.6255.6815.1162.50222.55417.34

Synageva BioPharma Corp Quarterly Data

BS_other_assets_Bank 140.80140.87235.18222.55317.88294.48442.81417.34586.37549.53
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial